Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001477932-20-002847
Filing Date
2020-05-15
Accepted
2020-05-15 17:02:25
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A curr_10ka.htm 10-K/A 118658
2 CERTIFICATION curr_ex311.htm EX-31.1 2800
3 CERTIFICATION curr_ex312.htm EX-31.2 2797
4 curr_10kaimg1.jpg GRAPHIC 4202
  Complete submission text file 0001477932-20-002847.txt   131255
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-55908 | Film No.: 20886552
SIC: 2673 Plastics, Foil & Coated Paper Bags